Press release

March 2014

SCILEX Pharmaceuticals Announces Filing of Investigational New Drug Application for Ztlido™

March 24, 2014

Pivotal pharmacokinetic bridging clinical study anticipated to begin in May. Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products for the treatment of pain, today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration for its first product Ztlido™ … Continue reading SCILEX Pharmaceuticals Announces Filing of Investigational New Drug Application for Ztlido™

SCILEX Pharmaceuticals Announces Completion of $5,000,000 Private Placement

March 21, 2014

Funds to be used for the clinical development of the Company’s first product Ztlido™ (lidocaine patch 1.8%) Malvern, PA – SCILEX Pharmaceuticals, Inc., today announced that the company has entered into definitive agreements for a private placement of common stock and warrants. The gross proceeds of the placement are expected to be approximately $5,000,000, before … Continue reading SCILEX Pharmaceuticals Announces Completion of $5,000,000 Private Placement
X

Share This Page

XS SM MD LG XL